Comparison of Bone Morphogenetic Protein-4 (BMP-4) and 7 Levels Between Control and Polycystic Ovarian Syndrome (PCOS) Patients.

NCT01162447 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2010-07-14

No results posted yet for this study

Summary

The investigators aim to compare the levels of bone morphogenetic protein-4 and -7 (BMP-4 and 7) in blood, follicular fluid and ovarian organ culture supernatant obtained from healthy subjects and polycystic ovarian syndrome (PCOS) patients.

Conditions

  • Polycystic Ovarian Syndrome

Sponsors & Collaborators

  • V.K.V. American Hospital, Istanbul

    lead OTHER

Principal Investigators

  • Bulent Urman, MD · VKV American Hospital Women's Health center

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01162447 on ClinicalTrials.gov